A Study to Determine the Safety and Efficacy of Oligopin® on Metabolic Risk Factors in Subjects With Metabolic Syndrome
Not Applicable
- Conditions
- Metabolic Syndrome
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Oligopin®
- First Posted Date
- 2020-07-28
- Last Posted Date
- 2021-08-26
- Lead Sponsor
- Les Derives Resiniques et Terpeniques
- Target Recruit Count
- 40
- Registration Number
- NCT04488653
- Locations
- 🇨🇦
KGK Science Inc., London, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath